טוען...
AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges
A number of simian and simian human immunodeficiency viruses (SIV and SHIV) have been used to assess the efficacy of HIV-1 vaccine strategies. Among these, SIVmac239 is considered among the most stringent because, unlike SHIV models, its full genome has co-evolved in its macaque host and its tier 3...
שמור ב:
| הוצא לאור ב: | Sci Transl Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6716512/ https://ncbi.nlm.nih.gov/pubmed/31341061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aau5409 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|